Literature DB >> 32843163

Comparability of asthma control test scores between self and physician-administered test.

Claudia Crimi1, Raffaele Campisi2, Alberto Noto3, Sabrina Genco4, Giulia Cacopardo5, Santi Nolasco6, Nunzio Crimi7.   

Abstract

BACKGROUND: The Asthma Control Test (ACT) is a tool that allows physicians to estimate the control of asthma symptoms on each patient in a quick way.
METHODS: We conducted a prospective single-center observational study enrolling 97 patients with asthma, selected from the Outpatient Respiratory Service of "Policlinico-Vittorio Emanuele" in Catania. Patients answered the ACT in full autonomy. Subsequently, the physician, blinded to the previous ACT evaluation, administered a new ACT and then assessed patients' medical condition during his/her visit. A second physician evaluated patients' level of symptom control according to GINA guidelines. Agreement in ACT score was analyzed using the Kendall coefficient of concordance (W) for ACT individual items and overall score. The impact of different education levels on the ACT was analyzed with the Mann-Whitney test. MAIN
FINDINGS: There was no significant difference in ACT total score obtained by either administration mode (p > 0.05). Responses to ACT single items showed a statistically significant difference between patients with lower and higher education levels in ACT items n°3 and 5, (p < 0.05), with lower education levels influencing patients symptom perception and disease control. Moreover, a significant difference in the evaluation of asthma control was found between ACT and GINA assessment of symptom control (p < 0.05).
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Asthma control test; GINA

Mesh:

Year:  2020        PMID: 32843163     DOI: 10.1016/j.rmed.2020.106015

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

1.  Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study.

Authors:  Ismael García-Moguel; Ana Rosado; Aída Gómez-Cardeñosa; Mar Gandolfo-Cano; Teresa Robledo Echarren; Maria Del Mar Moro Moro; Mª Del Mar Reaño Martos; Rafael Pineda-Pineda; Marcela Valverde-Monge; Cristina Martin-Arriscado Arroba; Javier Domínguez-Ortega
Journal:  J Asthma Allergy       Date:  2022-05-13

2.  Implementing asthma management guidelines in public primary care clinics in Malaysia.

Authors:  Ai Theng Cheong; Ping Yein Lee; Sazlina Shariff-Ghazali; Hani Salim; Norita Hussein; Rizawati Ramli; Hilary Pinnock; Su May Liew; Nik Sherina Hanafi; Ahmad Ihsan Abu Bakar; Azainorsuzila Mohd Ahad; Yong Kek Pang; Karuthan Chinna; Ee Ming Khoo
Journal:  NPJ Prim Care Respir Med       Date:  2021-11-29       Impact factor: 2.871

3.  Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study).

Authors:  Eva Martínez-Moragón; Ismael García-Moguel; Javier Nuevo; Gustavo Resler
Journal:  BMC Pulm Med       Date:  2021-12-18       Impact factor: 3.317

4.  Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study.

Authors:  Claudia Crimi; Raffaele Campisi; Santi Nolasco; Sebastian Ferri; Giulia Cacopardo; Pietro Impellizzeri; Maria Provvidenza Pistorio; Evelina Fagone; Corrado Pelaia; Enrico Heffler; Nunzio Crimi
Journal:  J Asthma Allergy       Date:  2021-11-30

5.  Persistent Eosinophilic Inflammation in Adult Asthmatics with High Serum and Urine Levels of Leukotriene E4.

Authors:  Ga-Young Ban; Seung-Hyun Kim; Hae-Sim Park
Journal:  J Asthma Allergy       Date:  2021-10-12

6.  The role of education in the self-compilation of asthma control test score in patients with asthma.

Authors:  Silvano Dragonieri; Vitaliano Nicola Quaranta; Enrico Scisci; Elena Capozza; Federica Barratta; Maria Luisa De Candia; Giovanna Elisiana Carpagnano
Journal:  Acta Biomed       Date:  2022-07-01

Review 7.  Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies.

Authors:  Luigi La Via; Filippo Sanfilippo; Giuseppe Cuttone; Veronica Dezio; Monica Falcone; Serena Brancati; Claudia Crimi; Marinella Astuto
Journal:  Eur J Clin Pharmacol       Date:  2022-08-26       Impact factor: 3.064

8.  Worsening of asthma control after COVID-19.

Authors:  Rosana Câmara Agondi; Natália Menechino; Ana Karolina Barreto Berselli Marinho; Jorge Kalil; Pedro Giavina-Bianchi
Journal:  Front Med (Lausanne)       Date:  2022-09-14

9.  Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program.

Authors:  Raffaele Campisi; Claudia Crimi; Santi Nolasco; Bianca Beghè; Leonardo Antonicelli; Gabriella Guarnieri; Nicola Scichilone; Morena Porto; Luigi Macchia; Giulia Scioscia; Maria Pia Foschino Barbaro; Alberto Papi; Nunzio Crimi
Journal:  J Asthma Allergy       Date:  2021-05-27

10.  Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data.

Authors:  Luis A Pérez de Llano; Borja G Cosío; Ignacio Lobato Astiárraga; Gregorio Soto Campos; Miguel Ángel Tejedor Alonso; Nuria Marina Malanda; Alicia Padilla Galo; Isabel Urrutia Landa; Francisco J Michel de la Rosa; Ismael García-Moguel
Journal:  J Asthma Allergy       Date:  2022-01-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.